Chidamide, a Histone Deacetylase Inhibitor, Combined With R‐ <scp>GemOx</scp> in Relapsed/Refractory Diffuse Large B‐Cell Lymphoma ( <scp>TRUST</scp> ): A Multicenter, Single‐Arm, Phase 2 Trial

Authors

Institutions

Publication Details

Journal
Cancer Medicine
Published
2025-05-01
DOI
https://doi.org/10.1002/cam4.70919
Citations
4
Primary Topic
Histone Deacetylase Inhibitors Research
Type
article
Field-Weighted Citation Impact
3.22

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Chidamide, a Histone Deacetylase Inhibitor, Combined With R‐ GemOx in Relapsed/Refractory Diffuse Large B‐Cell Lymphoma ( TRUST ): A Multicenter, Single‐Arm, Phase 2 Trial

Bingyi Wu, Zhiming Li, Danling Dai, Peng Sun et al.
4 citations
Cancer Medicine
Histone Deacetylase Inhibitors Research
3.22
article

Chidamide, a Histone Deacetylase Inhibitor, Combined With R‐ GemOx in Relapsed/Refractory Diffuse Large B‐Cell Lymphoma ( TRUST ): A Multicenter, Single‐Arm, Phase 2 Trial

Bingyi Wu, Zhiming Li, Danling Dai, Peng Sun, Yingxian Liu, Liye Zhong, Yuhong Lu, Qingqing Cai, Hui Zhou, Yi Cao, Runhui Zheng, Ning Su, Panpan Liu, Wenyu Li, Yuchen Zhang, Yongfeng Yang, Huo Tan, Liang Yang, Xu Ye, Yudan Wu, Lirong Li, Huiqiang Huang, Yi Xia, Qihua Zou, Y.C. Lai
article en
4 citations

Abstract

No abstract available for this paper.
Cancer MedicineVol. 14(9)
Guangzhou University of Chinese Medicine (CN), Sun Yat-sen University (CN), Second Affiliated Hospital of Guangzhou Medical University (CN), Sun Yat-sen Memorial Hospital (CN), First Affiliated Hospital of Guangzhou Medical University (CN), The First People's Hospital of Shunde (CN), Hunan Cancer Hospital (CN), Sun Yat-sen University Cancer Center (CN), Guangdong Provincial People's Hospital (CN), Guangzhou Chest Hospital (CN), Southern Medical University (CN), Guangzhou Medical University (CN)
Beijing Xisike Clinical Oncology Research Foundation, National Natural Science Foundation of China, National Key Research and Development Program of China
Good health and well-being
Openalex Percentile: Top 9%
Histone Deacetylase Inhibitors Research
3.22
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.